Drug company merger should benefit research

被引：0

作者：

Labreque, G

机构：

来源：

BRITISH MEDICAL JOURNAL | 1998年 / 316卷 / 7130期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：494 / 494

页数：1

共 50 条

[31] Drug company sued over research trial in Nigeria
Ahmed, K
LANCET, 2001, 358 (9284): : 815 - 815
[32] Drug merger A to Z
Emma Dorey
Adam Michael
Nature Biotechnology, 1999, 17 (1) : 7 - 7
[33] Drug merger alert
不详
CHEMICAL ENGINEER-LONDON, 1999, (691): : 6 - 6
[34] Veterinary drug merger
不详
CHEMISTRY IN BRITAIN, 1997, 33 (09) : 12 - 12
[35] Why Academic Medical Centers Should Ban Drug Company Gifts to Individuals
Strong, Carson
AMERICAN JOURNAL OF BIOETHICS, 2010, 10 (01): : 13 - 15
[36] Ofgem announces distribution company merger policy
不详
INTERNATIONAL GAS ENGINEERING AND MANAGEMENT, 2002, 42 (05): : 18 - 18
[37] NATION SHOULD REASSESS MERGER POLICY
BALDRIGE, M
AMERICAN MINING CONGRESS JOURNAL, 1984, 70 (21): : 2 - 2
[38] Company merger yields preamps for hard drives
不详
EDN, 1997, 42 (02) : S8 - S8
[39] MERGER AUTHORISATIONS AND THE PUBLIC BENEFIT TEST: WHAT ON EARTH IS A PUBLIC BENEFIT?
Allingham, Nicholas
AUSTRALIAN JOURNAL OF COMPETITION AND CONSUMER LAW, 2018, 25 (04): : 279 - 285
[40] DRUG INDUSTRY-PHARMACY BENEFIT MANAGEMENT COMPANY ALLIANCES - FEDS BEGIN INVESTIGATION
GATTY, B
HOSPITAL FORMULARY, 1994, 29 (09): : 661 - 662